Protocols in Revision

Head and Neck Tumors (Squamous Cell)

• Carboplatin 70 / Fluorouracil 600 / Radiation, Oropharyngeal Carcinoma PID 1708 V1.1

Breast Cancer

• STUDY - GAIN-2 - Pertuzumab 420 / Trastuzumab 6, Breast Cancer, neoadjuvant, cycle 2-4 PID 768 V1.1
• STUDY - GAIN-2 - Pertuzumab 840 / Trastuzumab 8, Breast Cancer, neoadjuvant, cycle 1 PID 767 V1.1

Multiple Myeloma

• Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Isatuximab 10, multiple myeloma, induction, IB, cycle 1 PID 41 V1.2
• Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Isatuximab 10, multiple myeloma, induction, IB, cycle 2-3 PID 42 V1.2

Ovarian Tumor

• Paclitaxel 175 / Carboplatin 7.5, Ovarian ca, adjuvant PID 1335 V1.2